Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berinert for prevention of antibody-mediated rejection in kidney transplant
NCT01134510Phase 2Completed
- Start
- Aug 2011
- Primary completion
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of c1-esterase inhibitor in antibody mediated rejection (AMR). Started Aug 2011; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
antibody mediated rejection (AMR)
Beyond the preview
Go deeper on NCT01134510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134510.